Management of Postoperative Nausea and Vomiting. How to Deal with Refractory PONV

Anesthesiology Clinics

Volumn 30, Issue 3, 2012, Pages 481-493

  Jokinen, Johanna ^a   Smith, Andrew F ^b   Roewer, Norbert ^a   Eberhart, Leopold H J ^c   Kranke, Peter ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b ROYAL LANCASTER INFIRMARY   (United Kingdom)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Enhanced recovery; Patient satisfaction; PONV; Postoperative complications; Postoperative nausea and vomiting; Recovery after anesthesia and surgery

Indexed keywords

2 PROPANOL; APREPITANT; CASOPITANT; CYCLIZINE; DEXAMETHASONE; DIMENHYDRINATE; DOLASETRON MESILATE; DROPERIDOL; FOSAPREPITANT; GRANISETRON; HALOPERIDOL; METOCLOPRAMIDE; MIDAZOLAM; ONDANSETRON; PALONOSETRON; PROPOFOL; ROLAPITANT; SCOPOLAMINE; TROPISETRON;

ACUPRESSURE; AGITATION; AKATHISIA; AMINOTRANSFERASE BLOOD LEVEL; ANXIETY; CLINICAL PRACTICE; CONFUSION; CONSTIPATION; DROWSINESS; DRUG EFFICACY; DRUG HALF LIFE; DRUG INDUCED HEADACHE; DYSKINESIA; DYSTONIA; DYSURIA; GLUCOSE BLOOD LEVEL; HALLUCINATION; HUMAN; HYPERTENSION; HYPOTENSION; INCIDENCE; INSOMNIA; POSTOPERATIVE CARE; POSTOPERATIVE NAUSEA AND VOMITING; PROPHYLAXIS; QT PROLONGATION; RECURRENT DISEASE; REVIEW; RISK FACTOR; SIDE EFFECT; TACHYCARDIA; VISUAL DISORDER; XEROSTOMIA;

ACUPRESSURE; ANTIEMETICS; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; HUMANS; POSTOPERATIVE NAUSEA AND VOMITING; RISK FACTORS;

EID: 84866401766     PISSN: 19322275     EISSN: 22103538     Source Type: Journal    
DOI: 10.1016/j.anclin.2012.07.003     Document Type: Review

References (65)

1. Franck M., Radtke F.M., Apfel C.C., et al. Documentation of post-operative nausea and vomiting in routine clinical practice. J Int Med Res 2010, 38(3):1034-1041.
2. Cohen M.M., Duncan P.G., DeBoer D.P., et al. The postoperative interview: assessing risk factors for nausea and vomiting. Anesth Analg 1994, 78(1):7-16.
3. Apfel C.C., Laara E., Koivuranta M., et al. A simplified risk score for predicting postoperative nausea and vomiting: conclusions from cross-validations between two centers. Anesthesiology 1999, 91(3):693-700.
4. Eberhart L.H., Morin A.M., Wulf H., et al. Patient preferences for immediate postoperative recovery. Br J Anaesth 2002, 89(5):760-761.
5. Blacoe D.A., Cunning E., Bell G. Paediatric day-case surgery: an audit of unplanned hospital admission Royal Hospital for Sick Children, Glasgow. Anaesthesia 2008, 63(6):610-615.
6. Schumann R., Polaner D.M. Massive subcutaneous emphysema and sudden airway compromise after postoperative vomiting. Anesth Analg 1999, 89(3):796-797.
7. Baric A. Oesophageal rupture in a patient with postoperative nausea and vomiting. Anaesth Intensive Care 2000, 28(3):325-327.
8. Atallah F.N., Riu B.M., Nguyen L.B., et al. Boerhaave's syndrome after postoperative vomiting. Anesth Analg 2004, 98(4):1164-1166.
9. Bremner W.G., Kumar C.M. Delayed surgical emphysema, pneumomediastinum and bilateral pneumothoraces after postoperative vomiting. Br J Anaesth 1993, 71(2):296-297.
10. Reddy S., Butt M.W., Samra G.S. A potentially fatal complication of postoperative vomiting: Boerhaave's syndrome. Eur J Anaesthesiol 2008, 25(3):257-259.
11. Toprak V., Keles G.T., Kaygisiz Z., et al. Subcutaneous emphysema following severe vomiting after emerging from general anesthesia. Acta Anaesthesiol Scand 2004, 48(7):917-918.
12. Kranke P., Eberhart L.H. Possibilities and limitations in the pharmacological management of postoperative nausea and vomiting. Eur J Anaesthesiol 2011, 28(11):758-765.
13. Kranke P., Schnabel A., Eberhart L.H., et al. Providing effective implementation of antiemetic strategies: the postoperative nausea and vomiting-free hospital is a laudable and realistic goal. Eur J Anaesthesiol 2011, 28(4):308-309.
14. Scuderi P.E., James R.L., Harris L., et al. Multimodal antiemetic management prevents early postoperative vomiting after outpatient laparoscopy. Anesth Analg 2000, 91(6):1408-1414.
15. Eberhart L.H., Frank S., Lange H., et al. Systematic review on the recurrence of postoperative nausea and vomiting after a first episode in the recovery room: implications for the treatment of PONV and related clinical trials. BMC Anesthesiol 2006, 6:14.
16. Rusch D., Arndt C., Martin H., et al. The addition of dexamethasone to dolasetron or haloperidol for treatment of established postoperative nausea and vomiting. Anaesthesia 2007, 62(8):810-817.
17. Tramer M.R. Rational control of PONV-the rule of three. Can J Anaesth 2004, 51(4):283-285.
18. Leslie K., Myles P.S., Chan M.T., et al. Risk factors for severe postoperative nausea and vomiting in a randomized trial of nitrous oxide-based vs nitrous oxide-free anaesthesia. Br J Anaesth 2008, 101(4):498-505.
19. Gan T.J. Risk factors for postoperative nausea and vomiting. Anesth Analg 2006, 102(6):1884-1898.
20. Carlisle J.B., Stevenson C.A. Drugs for preventing postoperative nausea and vomiting. Cochrane Database Syst Rev 2006, (3). CD004125.
21. Apfel C.C., Korttila K., Abdalla M., et al. A factorial trial of six interventions for the prevention of postoperative nausea and vomiting. N Engl J Med 2004, 350(24):2441-2451.
22. Franck M., Radtke F.M., Baumeyer A., et al. Anaesthesist 2010, 59(6):524-528. [in German].
23. Kooij F.O., Klok T., Hollmann M.W., et al. Decision support increases guideline adherence for prescribing postoperative nausea and vomiting prophylaxis. Anesth Analg 2008, 106(3):893-898.
24. Frenzel J.C., Kee S.S., Ensor J.E., et al. Ongoing provision of individual clinician performance data improves practice behavior. Anesth Analg 2010, 111(2):515-519.
25. Kazemi-Kjellberg F., Henzi I., Tramer M.R. Treatment of established postoperative nausea and vomiting: a quantitative systematic review. BMC Anesthesiol 2001, 1(1):2.
26. Tang D.H., Malone D.C. A network meta-analysis on the efficacy of serotonin type 3 receptor antagonists used in adults during the first 24 hours for postoperative nausea and vomiting prophylaxis. Clin Ther 2012, 34(2):282-294.
27. Carlisle J.B. A meta-analysis of prevention of postoperative nausea and vomiting: randomised controlled trials by Fujii et al. compared with other authors. Anaesthesia 2012, in press.
28. Kranke P., Apfel C.C., Eberhart L.H., et al. The influence of a dominating centre on a quantitative systematic review of granisetron for preventing postoperative nausea and vomiting. Acta Anaesthesiol Scand 2001, 45(6):659-670.
29. Kranke P., Apfel C.C., Roewer N., et al. Reported data on granisetron and postoperative nausea and vomiting by Fujii, et al. are incredibly nice!. Anesth Analg 2000, 90(4):1004-1007.
30. Kranke P., Wallenborn J., Roewer N., et al. Fraud or flawed? at the end of the day it may be the patient who pays the bill!. Clin Ther 2012, 34(5):1204-1206. [author reply: 1206-8].
31. Wong E.H., Clark R., Leung E., et al. The interaction of RS 25259-197, a potent and selective antagonist, with 5-HT3 receptors, in vitro. Br J Pharmacol 1995, 114(4):851-859.
32. Bajwa S.S., Bajwa S.K., Kaur J., et al. Palonosetron: a novel approach to control postoperative nausea and vomiting in day care surgery. Saudi J Anaesth 2011, 5(1):19-24.
33. Melton M.S., Klein S.M., Gan T.J. Management of postdischarge nausea and vomiting after ambulatory surgery. Curr Opin Anaesthesiol 2011, 24(6):612-619.
34. Park S.K., Cho E.J. A randomized, double-blind trial of palonosetron compared with ondansetron in preventing postoperative nausea and vomiting after gynaecological laparoscopic surgery. J Int Med Res 2011, 39(2):399-407.
35. Wang J.J., Ho S.T., Tzeng J.I., et al. The effect of timing of dexamethasone administration on its efficacy as a prophylactic antiemetic for postoperative nausea and vomiting. Anesth Analg 2000, 91(1):136-139.
36. Ormel G., Romundstad L., Lambert-Jensen P., et al. Dexamethasone has additive effect when combined with ondansetron and droperidol for treatment of established PONV. Acta Anaesthesiol Scand 2011, 55(10):1196-1205.
37. Kranke P., Morin A.M., Roewer N., et al. Dimenhydrinate for prophylaxis of postoperative nausea and vomiting: a meta-analysis of randomized controlled trials. Acta Anaesthesiol Scand 2002, 46(3):238-244.
38. Available at: Accessed September 7, 2012. http://www.ukmi.nhs.uk/applications/ndo/record_view_open.asp?newDrugID=4373.
39. Singla N.K., Singla S.K., Chung F., et al. Phase II study to evaluate the safety and efficacy of the oral neurokinin-1 receptor antagonist casopitant (GW679769) administered with ondansetron for the prevention of postoperative and postdischarge nausea and vomiting in high-risk patients. Anesthesiology 2010, 113(1):74-82.
40. Altorjay A., Melson T., Chinachoit T., et al. Casopitant and ondansetron for postoperative nausea and vomiting prevention in women at high risk for emesis: a phase 3 study. Arch Surg 2011, 146(2):201-206.
41. Gan T.J., Gu J., Singla N., et al. Rolapitant for the prevention of postoperative nausea and vomiting: a prospective, double-blinded, placebo-controlled randomized trial. Anesth Analg 2011, 112(4):804-812.
42. Apfel C.C., Malhotra A., Leslie J.B. The role of neurokinin-1 receptor antagonists for the management of postoperative nausea and vomiting. Curr Opin Anaesthesiol 2008, 21(4):427-432.
43. Kranke P., Morin A.M., Roewer N., et al. The efficacy and safety of transdermal scopolamine for the prevention of postoperative nausea and vomiting: a quantitative systematic review. Anesth Analg 2002, 95(1):133-143.
44. Apfel C.C., Zhang K., George E., et al. Transdermal scopolamine for the prevention of postoperative nausea and vomiting: a systematic review and meta-analysis. Clin Ther 2010, 32(12):1987-2002.
45. Ludwin D.B., Shafer S.L. Con: the black box warning on droperidol should not be removed (but should be clarified!). Anesth Analg 2008, 106(5):1418-1420.
46. Habib A.S., Gan T.J. Pro: the food and drug administration black box warning on droperidol is not justified. Anesth Analg 2008, 106(5):1414-1417.
47. Habib A.S., Gan T.J. The use of droperidol before and after the Food and Drug Administration black box warning: a survey of the members of the society of ambulatory anesthesia. J Clin Anesth 2008, 20(1):35-39.
48. FDA. 07/27/2009 [cited 2012 5th July]. Available at: Accessed July 5, 2012. http://www.fda.gov/safety/medwatch/safetyinformation/safetyalertsforhumanmedicalproducts/ucm173778.
49. George E., Hornuss C., Apfel C.C. Neurokinin-1 and novel serotonin antagonists for postoperative and postdischarge nausea and vomiting. Curr Opin Anaesthesiol 2010, 23(6):714-721.
50. Merker M., Kranke P., Morin A.M., et al. Anaesthesist 2011, 60(5):432-440. 442-5. [in German].
51. Henzi I., Walder B., Tramer M.R. Metoclopramide in the prevention of postoperative nausea and vomiting: a quantitative systematic review of randomized, placebo-controlled studies. Br J Anaesth 1999, 83(5):761-771.
52. Schaub I., Lysakowski C., Elia N., et al. Low-dose droperidol (
53. Wallenborn J., Gelbrich G., Bulst D., et al. Prevention of postoperative nausea and vomiting by metoclopramide combined with dexamethasone: randomised double blind multicentre trial. BMJ 2006, 333(7563):324.
54. Kranke P., Eberhart L. übelkeit und Erbrechen in der perioperativen Phase (PONV) 2012, Deutscher Ärzte-Verlag, Köln (Germany).
55. Habib A.S., Gan T.J. The effectiveness of rescue antiemetics after failure of prophylaxis with ondansetron or droperidol: a preliminary report. J Clin Anesth 2005, 17(1):62-65.
56. Gan T.J., Meyer T.A., Apfel C.C., et al. Society for Ambulatory Anesthesia guidelines for the management of postoperative nausea and vomiting. Anesth Analg 2007, 105(6):1615-1628.
57. Kovac A.L., O'Connor T.A., Pearman M.H., et al. Efficacy of repeat intravenous dosing of ondansetron in controlling postoperative nausea and vomiting: a randomized, double-blind, placebo-controlled multicenter trial. J Clin Anesth 1999, 11(6):453-459.
58. DeBalli P. The use of propofol as an antiemetic. Int Anesthesiol Clin 2003, 41(4):67-77.
59. Gan T.J., El-Molem H., Ray J., et al. Patient-controlled antiemesis: a randomized, double-blind comparison of two doses of propofol versus placebo. Anesthesiology 1999, 90(6):1564-1570.
60. Borgeat A., Wilder-Smith O.H., Wilder-Smith C.H., et al. Adjuvant propofol for refractory cisplatin-associated nausea and vomiting. Lancet 1992, 340(8820):679-680.
61. Lee A., Fan L.T. Stimulation of the wrist acupuncture point P6 for preventing postoperative nausea and vomiting. Cochrane Database Syst Rev 2009, (2). CD003281.
62. Pellegrini J., DeLoge J., Bennett J., et al. Comparison of inhalation of isopropyl alcohol vs promethazine in the treatment of postoperative nausea and vomiting (PONV) in patients identified as at high risk for developing PONV. AANA J 2009, 77(4):293-299.
63. Cotton J.W., Rowell L.R., Hood R.R., et al. A comparative analysis of isopropyl alcohol and ondansetron in the treatment of postoperative nausea and vomiting from the hospital setting to the home. AANA J 2007, 75(1):21-26.
64. Teran L., Hawkins J.K. The effectiveness of inhalation isopropyl alcohol vs. granisetron for the prevention of postoperative nausea and vomiting. AANA J 2007, 75(6):417-422.
65. Radford K.D., Fuller T.N., Bushey B., et al. Prophylactic isopropyl alcohol inhalation and intravenous ondansetron versus ondansetron alone in the prevention of postoperative nausea and vomiting in high-risk patients. AANA J 2011, 79(Suppl 4):S69-S74.